Bond.az White LogoBond.az Black Logo

Rosenblatt Raises 8x8 Target to $3.00

Rosenblatt raises 8x8 stock target to $3.00 after strong Q4 results. Revenue beat guidance.

Robert Moore
ByRobert Moore- Senior Editor
|
0

Bond.az reports that Rosenblatt raised its price target on 8x8 Inc. (NASDAQ:EGHT) to $3.00 from $2.75, maintaining a Buy rating. The stock currently trades at $2.41.

8x8 delivered Q4 fiscal 2026 results exceeding guidance. Total revenue hit $185.2 million, with service revenue at a record $180.2 million. Operating margin was 10.7%.

Rosenblatt raised fiscal 2027 estimates to $740 million revenue and $0.36 EPS. The new target reflects 0.9 times calendar 2027 sales of $737 million.

More News
Today / 12:32
|
782

Deutsche Bank upgrades Centene stock on earnings recovery

Deutsche Bank upgrades Centene stock to Buy with a new price target of $80. Bond.az analysis highlights undervaluation. Latest news on Centene.

0
Today / 12:31
|
743

Deutsche Bank upgrades Elevance stock

Deutsche Bank upgraded Elevance Health to Buy with a $498 price target, citing stable managed care market. Strong Q1 results also boost confidence.

0
Today / 12:11
|
261

BMO Raises Israel Chemicals Target Price on Potash

BMO Capital raises Israel Chemicals price target to $6.50 on strong potash outlook and higher EBITDA guidance.

0
Today / 12:10
|
222

Cantor Fitzgerald raises PANW price target to $285

Cantor Fitzgerald raises Palo Alto Networks price target to $285, citing platformization, AI tailwinds, and strong partner results.

0
Today / 11:53
|
435

Stifel Maintains Manhattan Associates Price Target

Stifel maintains Buy rating and $200 target for Manhattan Associates. The company is investing in cloud migration and agentic AI capabilities.

0
Today / 11:52
|
385

Piper Sandler Reiterates Alphabet Overweight on AI

Piper Sandler reiterates Alphabet Overweight rating and $425 target after Google I/O AI product launches.

0
Today / 11:51
|
464

Rosenblatt Cuts Canaan Target Price to $1.30

Rosenblatt cuts Canaan stock price target to $1.30 from $2.25, maintains Buy rating. Canaan faces revenue miss in Q1 FY2026.

0
Today / 11:50
|
872

Bernstein raises Dell target to $280 on AI

Bernstein raises Dell price target to $280, citing agentic AI demand and SMCI share losses.

0
Today / 11:43
|
228

Alpha Tau Stock Gets Buy Rating, $15 Target

H.C. Wainwright reiterates Buy on Alpha Tau stock with $15 target. Company completes ReSTART trial enrollment.

0
Today / 11:42
|
472

H.C. Wainwright Reiterates Protara Buy Rating

H.C. Wainwright reiterates Buy rating on Protara Therapeutics (TARA) with $27 target. Encouraging results from lymphatic malformation and bladder cancer trials.

0
Today / 11:41
|
612

H.C. Wainwright reiterates MindWalk stock rating on platform validation

H.C. Wainwright reiterates Buy rating and $5 target on MindWalk stock, citing platform validation and strong pipeline. Read more.

0
Today / 11:40
|
376

Traws Pharma Gets $8 Price Target from H.C. Wainwright

H.C. Wainwright reaffirms Buy on Traws Pharma with $8 target. Financing secured for influenza drug trial. Read more on Bond.az.

0
...